Physician profile
Jim E Brewer
NPI 1275599987
$1,090.31
in general payments reported to CMS, 2019-2025
16 companies · $311 in 2025
The $311 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $93.12 · 2020: $66.38 · 2021: $24.61 · 2022: $150 · 2023: $244 · 2024: $202 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $757.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $756.62 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Supernus Pharmaceuticals, INC. | $279.18 | 2023-2025 | Qelbree, Qelbree |
| Abbott Laboratories | $179.00 | 2022-2025 | Freestyle Libre 3 |
| Lilly USA, LLC | $140.63 | 2021-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $81.48 | 2023-2025 | Jardiance |
| Novo Nordisk INC | $55.56 | 2019-2024 | Rybelsus, Ozempic |
| Allergan, INC. | $52.71 | 2019-2020 | |
| Merck Sharp & Dohme LLC | $50.69 | 2022-2025 | Vaxneuvance, Capvaxive, Gardasil 9 |
| Amgen INC. | $48.44 | 2023 | Prolia, Evenity |
| Glaxosmithkline, LLC. | $44.56 | 2023-2024 | Trelegy Ellipta, Pediarix, Bexsero |
| Sanofi Pasteur INC. | $30.68 | 2022-2023 | |
| Pfizer INC. | $30.61 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $28.20 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $25.23 | 2019 | |
| Biomerieux INC | $18.50 | 2025 | |
| Teva Pharmaceuticals USA, INC. | $13.54 | 2020 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $11.30 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jim Brewer listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.